Impact of Concomitant Hormone Therapy on the Diagnostic Performance of 18F-Piflufolastat PET/CT in Prostate Cancer ...
This study investigates the impact of hormone therapy (HT) on the diagnostic performance of 18F-piflufolastat PET/CT in OSPREY (NCT02981368) cohort B patients with recurrent or metastatic prostate cancer. 18F-piflufolastat PET/CT was evaluated in …